Miyajima K, Yanagisawa T, Suzuki H, Fukuokaya W, et al. Comparison of Quality of Life and Injection Site Reactions After Switching from Degarelix 80 mg to 480 mg in Advanced Prostate Cancer: A Prospective Trial. Anticancer Res 2023;43:1611-1621.
PMID: 36974827